MJ

Manish Jaiswal

Active Director Director DIN 10792409
DIN 10792409 First appointment Sep 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Manish Jaiswal

Data last updated:

Manish Jaiswal is a Director at Medibrave Healthcare Private Limited (since 2024).

DIN 10792409
Primary Designation Director
First Appointment 28 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medibrave Healthcare Private Limited U47721UP2024PTC209935
Director28 Sep 20242024Active

Board colleagues of Manish Jaiswal

NameDINCompanyDesignation
Vandana Jaiswal10792410Medibrave Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medibrave Healthcare Private Limited
Premium access

Shareholding and investment profile for Manish Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Jaiswal

Manish Jaiswal currently holds 1 directorship: Medibrave Healthcare Private Limited (Director, since 28 Sep 2024).

Manish Jaiswal was first appointed on 28 Sep 2024 as Director at Medibrave Healthcare Private Limited.

The current boards of Manish Jaiswal's companies include Vandana Jaiswal (Medibrave Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available